NAS:ESPR (USA) Also Trade In: Germany UK

Esperion Therapeutics Inc $ 42.37 1.43 (3.49%)

Volume:
626,824
Avg Vol (1m):
700,213
Market Cap $:
1.17 Bil
Enterprise Value $:
1.02 Bil
P/E (TTM):
0.00
P/B:
0.00
Warning! GuruFocus has detected 3 Severe warning signs with ESPR. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

3/10
Current Vs Industry Vs History
Cash-To-Debt 27.93
Equity-to-Asset -0.28
Debt-to-Equity -0.11
Debt-to-EBITDA -0.02
N/A
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.89
DISTRESS
GREY
SAFE
Beneish M-Score -16.51
Not Manipulator
Manipulator
WACC vs ROIC
ROIC -2756.87 %
WACC 9.62 %

Profitability Rank

Current Vs Industry Vs History
Operating Margin % -5318.2
Net Margin % -5492.02
ROE % -383.57
ROA % -109.99
ROC (Joel Greenblatt) % -8839.74
3-Year EBITDA Growth Rate 0.2
3-Year EPS without NRI Growth Rate -2.5

Valuation Rank

Current Vs Industry Vs History
PS Ratio 242.11
EV-to-EBIT -4.05
N/A
EV-to-EBITDA -4.05
N/A
EV-to-Revenue 212.85
Current Ratio 2.35
Quick Ratio 2.33
Days Inventory 4335.26
Days Payable 177955.16

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.3

Valuation & Return

Current Vs Industry Vs History
Earnings Yield (Greenblatt) % -24.69